EICHOR
● Terminated
A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion
Condition: Degenerative Disc Disease · Sponsor: Angitia Biopharmaceuticals
About this study
The primary objective of the study is to assess the overall efficacy of a single intervertebral local administration of AGA111 in patients with degenerative disc disease undergoing lumbar interbody fusion.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (35)
| Beijing Jishuitan Hospital | Beijing, Beijing Municipality, China | — |
| Beijing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | — |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | — |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | — |
| Xuanwu Hospital Capital Medical University | Beijing, Beijing Municipality, China | — |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou, Fujian, China | — |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | — |
| Nanfang Hospital | Guangzhou, Guangdong, China | — |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | — |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | — |
| Yuebei People's Hospital | Shaoguan, Guangdong, China | — |
+ 23 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06115512